Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Stock Option Activity (Details)

v3.23.2
Stock-Based Compensation - Stock Option Activity (Details) - Tecogen - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2021
Jun. 30, 2023
Dec. 31, 2022
Stock Options Outstanding [Roll Forward]        
Beginning (shares) 3,204,297   3,204,297  
Granted (shares)     125,000  
Exercised (shares)     0  
Canceled and forfeited (shares)     (42,000)  
Ending (shares)     3,287,297  
Exercisable (shares)     1,788,972  
Vested and expected to vest (shares)     3,062,548  
Exercise Price Per Share [Abstract]        
Exercise Price Per Share, Outstanding, Minimum (per share) $ 0.71   $ 0.71  
Exercise Price Per Share, Outstanding, Maximum (dollars per share) 10.33   10.33  
Weighted Average Exercise Price [Roll Forward]        
Beginning (usd per share) $ 1.61   1.61  
Granted (usd per share)     1.11  
Canceled and forfeited (usd per share)     2.98  
Ending (usd per share)     1.57  
Exercisable (usd per share)     2.06  
Vested and expected to vest (usd per share)     $ 1.61  
Weighted Average Remaining Life   7 years 3 months 18 days 7 years  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Outstanding, Aggregate Intrinsic Value     $ 406,845 $ 882,074
Exercisable, Aggregate Intrinsic Value     206,145  
Vested and expected to vest, Aggregate Intrinsic Value     $ 376,740  
Minimum        
Exercise Price Per Share [Abstract]        
Exercise price per share, Granted (dollars per share)     $ 1.10